Editorial
Rev Panam Salud Publica 40(6), 2016
Policy Brief
published: 16 March 2018 doi: 10.3389/fpubh.2018.00069
Sources: National Commitment and Policy Instrument, 2019
10 years after the UN general assembly special session on drugs
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0189770 January 2, 2018
July 2014
This report was made possible through support provided by the One Million Community Health Workers Campaign, mPowering Frontline Health Workers, Intel, and USAID. This report was authored by Cindil Redick for mPowering Frontline Health Workers under the terms of Contract No. GHS-A-00-08...-00002-00. The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID.
more
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...table of all major issues in PLWH, recommendations on antiretroviral treatment, drug-drug interactions, diagnosis, monitoring and treatment of co-morbidities, co-infections and opportunistic diseases.
Available in English, French, Spanish, German, Portuguese, Russian, Chinese and Japanese
more